Dopamine agonists induce recovery from surgically-induced septal rage

Are reactions to frustrative nonreward in other animals a model for human anger? Neurobehavioral implications and therapeutic applications.

Behavioral neuroscience·2023

How it ends: A review of behavioral and psychological phenomena, physiological processes and neural circuits in the termination of aggression in other animals and anger in people.

Behavioural brain research·2023

Predicting population responses to environmental change from individual-level mechanisms: towards a standardized mechanistic approach.

Proceedings. Biological sciences·2019

Development and initial characterization of a novel ghrelin receptor CRISPR/Cas9 knockout wistar rat model.

International journal of obesity (2005)·2018

Molecular mechanisms of group I metabotropic glutamate receptor mediated LTP and LTD in basolateral amygdala in vitro.

Psychopharmacology·2016

The Neurobehavioral Phenotype in Mucopolysaccharidosis Type IIIB: an Exploratory Study.

Molecular genetics and metabolism reports·2016

Wake-activated neuronal populations that regulate sleep drive.

Nature·2026

Observation of conformal field theory spectra in a quantum simulator.

Nature·2026

Human brain organoids record the passage of time over multiple years.

Nature·2026

Discovery of a star sensitive to the spin of Sagittarius A.

Nature·2026

Asymmetric prefrontal representations for leader-follower dynamics.

Nature·2026

Family genetic designs in MoBa provide insights into health and functioning.

Nature·2026

Structural Modifications of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): New Horizons in Antimicrobial Drug Discovery.

Archiv der Pharmazie·2026

Benzophenone Derivatives as a New Class of Anti-Infectives Against Acanthamoeba spp.

Archiv der Pharmazie·2026

Novel 1H-Indole-3-carboxamide Derivatives as CDK4 Inhibitors for Treating Cancer.

ACS medicinal chemistry letters·2026

Novel Heterocyclic Compounds for Treating HIV Infection.

ACS medicinal chemistry letters·2026

Novel 6,5-Bicyclic Compounds as 5‑HT2A Receptor Agonists for Treating Depression, Anxiety, Substance Abuse, and Headaches.

ACS medicinal chemistry letters·2026

Advancing Next-Generation Psychedelic Therapeutics through Selective 5‑HT2A Activation, Precision Aerosol Delivery, and Optimized 5‑MeO-DMT Treatment Paradigms.

ACS medicinal chemistry letters·2026

Related Experiment Videos

Dopamine agonists induce recovery from surgically-induced septal rage

Related Concept Videos

Are reactions to frustrative nonreward in other animals a model for human anger? Neurobehavioral implications and therapeutic applications.

How it ends: A review of behavioral and psychological phenomena, physiological processes and neural circuits in the termination of aggression in other animals and anger in people.

Predicting population responses to environmental change from individual-level mechanisms: towards a standardized mechanistic approach.

Development and initial characterization of a novel ghrelin receptor CRISPR/Cas9 knockout wistar rat model.

Molecular mechanisms of group I metabotropic glutamate receptor mediated LTP and LTD in basolateral amygdala in vitro.

The Neurobehavioral Phenotype in Mucopolysaccharidosis Type IIIB: an Exploratory Study.

Wake-activated neuronal populations that regulate sleep drive.

Observation of conformal field theory spectra in a quantum simulator.

Human brain organoids record the passage of time over multiple years.

Discovery of a star sensitive to the spin of Sagittarius A.

Asymmetric prefrontal representations for leader-follower dynamics.

Family genetic designs in MoBa provide insights into health and functioning.

Structural Modifications of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): New Horizons in Antimicrobial Drug Discovery.

Benzophenone Derivatives as a New Class of Anti-Infectives Against Acanthamoeba spp.

Novel 1H-Indole-3-carboxamide Derivatives as CDK4 Inhibitors for Treating Cancer.

Novel Heterocyclic Compounds for Treating HIV Infection.

Novel 6,5-Bicyclic Compounds as 5‑HT2A Receptor Agonists for Treating Depression, Anxiety, Substance Abuse, and Headaches.

Advancing Next-Generation Psychedelic Therapeutics through Selective 5‑HT2A Activation, Precision Aerosol Delivery, and Optimized 5‑MeO-DMT Treatment Paradigms.

Related Experiment Videos

Dopamine agonists induce recovery from surgically-induced septal rage

Related Concept Videos

Related Articles